Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Study Finds No Link Between Thryoid Cancer and Ozempic, Mounjaro, Other GLP-1 Medications There was little difference in thyroid cancer rates among Ozempic and Mounjaro users, compared to those who took Januvia, Onglyza and similar diabetes medications. May 6, 2024 Irvin Jackson Add Your Comments Amid the growing popularity of Ozempic, Mounjaro and other new-generation diabetes and weight-loss drugs, there have been lingering concerns about potential side effects users may face, including long-term gastrointestinal problems, pancreatitis, gallbladder disease and potentially cancer. However, a recent study found that there is no evidence that users face an increased risk of thyroid cancer. Ozempic and Mounjaro are both part of a new class of medications, known as glucagon-like peptide 1 (GLP-1) receptor agonists, which prior studies have suggested may increase the rate of thyroid C cell tumors among rats, leading the FDA to require a prominent warning about the potential risk and counter-indicate use of the medications among individuals with a personal or family history of medullary thyroid carcinoma (MTC). In a study published last month in The BMJ, Swedish researchers were unable to find any statistically significant thyroid cancer risk among users from Denmark, Norway and Sweden, compared to users of another class of diabetes drugs, known as dipeptidyl peptidase 4 (DPP4) inhibitors, which include drugs like Januvia, Onglyza and Nesin. GLP-1 Side Effects Ozempic and Mounjaro were originally approved for treatment of type 2 diabetes, but they have been hailed as breakthrough weight loss treatments, leading to the widespread use by individuals throughout the United States. Unfortunately, adoption of the drugs has outpaced the ability of independent researchers to complete thorough studies on the potential side effects of GLP-1, and several safety signals have already emerged among users, most notably involving the development of a painful and debilitating stomach paralysis among some users, known as gastroparesis, which has resulted in a number of Ozempic lawsuits and Mounjaro lawsuits being filed against the drug makers, each raising nearly identical allegations that drug makers withheld critical information from consumers and the medical community to increase profits. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION To review the potential Mounjaro and Ozempic thyroid cancer risk, researchers in this latest study looked at data on more than 145,000 patients between 2007 through 2021, comparing those who started treatment with GLP-1 RA inhibitors to those who received DPP4 inhibitors. Patients who took drugs like Januvia and Onglyza experienced 1.33 thyroid cancer events per 10,000 person years, compared to 1.46 events per 10,000 person years among those taking Ozempic, leading researchers to conclude that there is no current evidence of an increased risk linked to GLP-1 RA inhibitors. “In this cohort study using nationwide data from three countries, GLP1 receptor agonist use was not associated with a substantially increased risk of thyroid cancer over a mean follow-up of 3.9 years,” the researchers concluded. “In absolute terms, this translates to no more than 0.36 excess events per 10 000 person years, which should be interpreted against the background incidence of 1.46 per 10 000 person years in the comparator group in the study population.” European regulators came to a similar conclusion in October of 2023. GLP-1 Stomach Paralysis Lawsuits While the findings may alleviate concerns over thyroid cancer linked to the popular medications, health experts still voice growing concerns over stomach paralysis, intestinal blockages and other potential side effects, as well as a growing number of lawsuits. Given common questions of fact and law raised in a growing number of complaints brought throughout the federal court system, the U.S. Judicial Panel on Multidistrict Litigation (JPML) decided in February 2024 to centralize all gastroparesis lawsuits involving any GLP-1 medication before U.S. District Judge Gene E.K. Pratter in the U.S. District Court for the Eastern District of Pennsylvania, as part of an MDL, or multidistrict litigation. As lawyers continue to review and file claims in the coming months, it is widely expected that thousands of Ozempic lawsuits, Mounjaro lawsuits and other gastroparesis claims will be transferred to the MDL, as nearly 2% of the U.S. population has been prescribed one of the GLP-1 medications, either for diabetes treatment or weight loss. To help gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation, Judge Pratter will likely establish a bellwether process to prepare a small group of lawsuits involving gastroparesis side effects for early trial dates. However, if the parties are unable to negotiate GLP-1 settlements or another resolution for the litigation after the bellwether trials, the Court may later remand each case back to the U.S. District Court where it was originally filed for trial. Tags: Diabetes, Diabetes Drugs, Gastroparesis, Januvia, Mounjaro, Novo Nordisk, Onglyza, Ozempic, Stomach Paralysis, Thyroid Cancer, Wegovy, Weight Loss Find Out If You Qualify for Ozempic or Wegovy Compensation More Ozempic, Wegovy and Mounjaro Lawsuit Stories Ozempic NAION Side Effects Result in Vision Loss Warnings by European Regulators June 9, 2025 Ozempic Lawsuit Alleges Woman Experienced Severe Bowel Obstruction Injuries June 3, 2025 Lawsuit Indicates Side Effects of Ozempic Caused Woman’s Stomach Paralysis, Blood Clots May 27, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Reports Highlight Sports Betting Addiction Problems Among Young Men (Posted: yesterday) Sports betting sites are fostering gambling addiction in young men nationwide, according to recent reports. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Alleges DraftKings Daily Fantasy Games Constitute Illegal Sports Gambling in California (06/05/2025)DraftKings Faces Lawsuit Over Failure To Pay Winning Bets (05/29/2025)Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study (05/16/2025) Tepezza Tinnitus and Hearing Loss Lawsuits Move Into Expert Discovery Phase (Posted: yesterday) Four Tepezza tinnitus and hearing loss lawsuits continue to be prepared for early trial dates next year, as plaintiffs’ lawyers submit case-specific expert reports this week. MORE ABOUT: TEPEZZA HEARING LOSS LAWSUITTepezza Lawyers Meet With MDL Judge To Review Status of Hearing Loss Lawsuits Today (03/31/2025)Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026 (03/25/2025)Court Identifies 4 Tepezza Lawsuits Over Hearing Loss for Early Bellwether Trials (02/11/2025) Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (Posted: 2 days ago) The makers of the Depo-Provera birth control shot are asking the Pennsylvania court system to consolidate before one state judge all lawsuits over claims the injections caused brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Indicates Depo-Provera Meningioma Growth Risks Created Constant Distress (06/06/2025)Lawsuit Alleges Intracranial Meningioma From Depo-Provera Resulted in Need for Lifelong Medical Monitoring (05/28/2025)Depo-Provera Lawsuit Sign Ups Expected To Continue as First Brain Tumor Cases Prepared for Trial (05/23/2025)
Reports Highlight Sports Betting Addiction Problems Among Young Men (Posted: yesterday) Sports betting sites are fostering gambling addiction in young men nationwide, according to recent reports. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Alleges DraftKings Daily Fantasy Games Constitute Illegal Sports Gambling in California (06/05/2025)DraftKings Faces Lawsuit Over Failure To Pay Winning Bets (05/29/2025)Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study (05/16/2025)
Tepezza Tinnitus and Hearing Loss Lawsuits Move Into Expert Discovery Phase (Posted: yesterday) Four Tepezza tinnitus and hearing loss lawsuits continue to be prepared for early trial dates next year, as plaintiffs’ lawyers submit case-specific expert reports this week. MORE ABOUT: TEPEZZA HEARING LOSS LAWSUITTepezza Lawyers Meet With MDL Judge To Review Status of Hearing Loss Lawsuits Today (03/31/2025)Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026 (03/25/2025)Court Identifies 4 Tepezza Lawsuits Over Hearing Loss for Early Bellwether Trials (02/11/2025)
Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (Posted: 2 days ago) The makers of the Depo-Provera birth control shot are asking the Pennsylvania court system to consolidate before one state judge all lawsuits over claims the injections caused brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Indicates Depo-Provera Meningioma Growth Risks Created Constant Distress (06/06/2025)Lawsuit Alleges Intracranial Meningioma From Depo-Provera Resulted in Need for Lifelong Medical Monitoring (05/28/2025)Depo-Provera Lawsuit Sign Ups Expected To Continue as First Brain Tumor Cases Prepared for Trial (05/23/2025)